In an in vivo study, a low dose of MAMPH exposure regulated beta-amyloid precursor protein-cleaving secretases and stimulated the soluble amyloid precursor protein alpha for improving cognitive functions in AD patients (Shukla et al., 2019). The gene discussed is APP; the disease is Alzheimer disease.